Cargando…

影像计划和实时引导肺癌穿刺活检在生物标志物检测中的进展

With the progress of targeted therapy and immunotherapy for lung cancer, the clinical demand for lung biopsy is increasing. An ideal biopsy specimen can be used not only for histopathological diagnosis, but also for biomarker detection. The ideal biopsy specimen should meet two requirements, includi...

Descripción completa

Detalles Bibliográficos
Autores principales: BAI, Gengshen, ZHU, Bingyin, MA, Jun, LI, Yongchun, HUANG, Gang, MA, Yaqiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial board of Chinese Journal of Lung Cancer 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558762/
https://www.ncbi.nlm.nih.gov/pubmed/37752543
http://dx.doi.org/10.3779/j.issn.1009-3419.2023.106.15
Descripción
Sumario:With the progress of targeted therapy and immunotherapy for lung cancer, the clinical demand for lung biopsy is increasing. An ideal biopsy specimen can be used not only for histopathological diagnosis, but also for biomarker detection. The ideal biopsy specimen should meet two requirements, including more than 60 mm(2) of tumor tissue and containing more than 20% of tumor cells. In order to obtain ideal lung cancer biopsy specimens, advanced imaging techniques are needed to help. In this article, we reviewed the requirements for biopsy specimens based on biomarker detection, as well as the current status and research progress of using imaging techniques for preoperative planning and intraoperative real time guidance of lung cancer biopsy.